In vitro drug sensitivity testing in human gliomas Journal Article


Authors: Kimmel, D. W.; Shapiro, J. R.; Shapiro, W. R.
Article Title: In vitro drug sensitivity testing in human gliomas
Abstract: In vitro drug sensitivity assays have been developed with the goal of predicting the clinical response to chemotherapy. The colony-forming assay, radiolabeled precursor inhibition assay, and microcytotoxicity assay are most commonly used. In retrospective studies, the assays correctly predict clinical response to a chemotherapeutic agent in 50% to 70% of patients and predict clinical resistance in nearly 100% of patients. All of the assays suffer from technical and theoretical problems. In vitro assays depend on cell culture and therefore do not entirely simulate in vivo conditions. Heterogeneity in chemosensitivity is commonly found and can complicate the interpretation of results. Further investigation is needed to determine if these assays will be able to select prospective chemotherapy for patients. The malignant origin of the cells in culture must be verified if meaningful conclusions are to be made.
Keywords: human cell; chemotherapy; glioma; cytotoxicity; in vitro study; central nervous system; cell culture; drug sensitivity; therapy; nervous system; intoxication; human; priority journal
Journal Title: Journal of Neurosurgery
Volume: 66
Issue: 2
ISSN: 0022-3085
Publisher: American Association of Neurological Surgeons  
Date Published: 1987-02-01
Start Page: 161
End Page: 171
Language: English
DOI: 10.3171/jns.1987.66.2.0161
PUBMED: 3543252
PROVIDER: scopus
DOI/URL:
Notes: Review -- Export Date: 5 February 2021 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. William R. Shapiro
    42 Shapiro
  2. Joan Rankin Shapiro
    27 Shapiro